Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration | Zendy

Youlan L. Gu | Zendy; Marthe A. Kampinga | Zendy; Wouter G. Wieringa | Zendy; Marieke L. Fokkema | Zendy; Maarten W. Nijsten | Zendy; Hans L. Hillege | Zendy; Ad F.M. van den Heuvel | Zendy; EngShiong Tan | Zendy; Gabija Pundziūtė | Zendy; Rik van der Werf | Zendy; Siyrous Hoseyni Guyomi | Zendy; Iwan C.C. van der Horst | Zendy; Felix Zijlstra | Zendy; Bart J.G.L. de Smet | Zendy

Open Access

Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration

Author(s) -

Youlan L. Gu,

Marthe A. Kampinga,

Wouter G. Wieringa,

Marieke L. Fokkema,

Maarten W. Nijsten,

Hans L. Hillege,

Ad F.M. van den Heuvel,

EngShiong Tan,

Gabija Pundziūtė,

Rik van der Werf,

Siyrous Hoseyni Guyomi,

Iwan C.C. van der Horst,

Felix Zijlstra,

Bart J.G.L. de Smet

Publication year - 2010

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.110.002741

Subject(s) - medicine , abciximab , percutaneous coronary intervention , myocardial infarction , cardiology , st segment , coronary thrombosis , clopidogrel , anesthesia

administration of the glycoprotein IIb/IIIa inhibitor abciximab is an effective adjunctive treatment strategy during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Although small-scale studies have suggested beneficial effects of intracoronary over intravenous administration of abciximab, this has not been investigated in a medium-scale randomized clinical trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research